Bioassay-guided fractionation of the EtOH extract of the aerial parts of Baccharis uncinella C. DC. (Asteraceae) led to identification of two cinnamic acid derivatives (caffeic and ferulic acids), two flavones (hispidulin and pectolinaringenin) and a mixture of three chlorogenic acids (3,4-, 3,5-and 4,5-Odicaffeoylquinic acids), which displayed in vitro anti-trypanosomal activity. Pectolinaringenin, hispidulin and caffeic acid showed activity against trypomastigotes of Trypanosoma cruzi, exhibiting 50% inhibitory concentration (IC 50 ) values of 52, 81 and 56 g/mL, respectively, while the chlorogenic acid mixture showed an IC 50 value of 61 g/mL. The flavonoids and cinnamic acid derivatives were evaluated for cytotoxicity against NCTC cells resulting in a 50% cytotoxic concentration (CC 50 ) ranging from 33.82 to 129.1 g/mL while the chlorogenic acids did not display cytotoxicity (CC 50 >150 g/mL). This is the first report of anti-trypanosomal activity of compounds from B. uncinella.
Chagas disease is one of the most neglected infectious diseases in underdeveloped and developing countries [1] . The World Health Organization (WHO) estimates that 23,000 deaths occur annually from Chagas disease [2] [3] . The disease is caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), which is transmitted to humans by triatomine insects primarily through their fecal matter, by blood transfusion, and by congenital transmission [4] . The therapeutic arsenal is very limited, and most of the compounds used produce toxic side effects, and are ineffective against the chronic phase of the disease [5] . Current drugs used in the early stages of the disease are Nifurtimox and Benznidazole, but these may lead to liver and renal failures [6] . For this reason, a continued search for anti-trypanosomal compounds from plants is justified.
The genus Baccharis comprises approximately 500 species in South and Central America and produces several classes of natural products including flavonoids and terpenes [7] . Plants from this genus have been used in folk medicine as an antiseptic, an antiinflammatory, to treat headaches [8] , cytotoxicity and antimicrobial, antifungal and antiviral infections [7] . Previous studies led to the isolation of several bioactive compounds from Baccharis species [9] [10] [11] and demonstrated that crude extracts as well as purified compounds from Baccharis retusa [9, 10] and B. dracunculifolia [12] , had promising anti-trypanosomal activity. Additionally, the isolation of antileishmanial triterpenoids, flavones, flavanones, and caffeic/ferulic acids from B. uncinella has been reported [13] . This paper reports the anti-trypanosomal activity of phenolic derivatives from B. uncinella and their in vitro cytotoxicity against mammalian cells.
The EtOH extract of the aerial parts of B. uncinella displayed activity against T. cruzi trypomastigote forms and was subjected to bio-assay guided fractionation providing compounds 1-7. Compounds 1 and 2 were characterized as derivatives of cinnamic acid by analysis of their 1 H NMR spectra, in which were observed typical signals of a trans-alkene system at  7.43/7.50 (d, J = 16.0 Hz, H-7) and 6.25/6.30 (d, J = 16.0 Hz, H-8), as well as multiplets at  6.70-7.10, assigned to H-2, H-5 and H-6. The spectrum of 2 had an intense peak at  3.67, assigned to a methoxyl group. Comparison with the 1 H and 13 C NMR data in the literature [14] allowed the identification of caffeic (1) and ferulic (2) acids. The 1 H NMR spectra of compounds 3 and 4 showed two singlets of flavone derivatives at  6.49/6.59 (H-3) and  6.55/6.76 (H-8) as well as two doublets at  6.85/6.90 (J = 8. intense singlets were observed at  3.81 (3H) and  3.73 (6H) in the spectra of 3 and 4, respectively, corresponding to methoxyl groups. Comparison of spectroscopic data, including 13 C NMR, with those reported in the literature, allowed the identification of compounds as hispidulin (3) [15] and pectolinaringenin (4) [16] . Compounds 5-7 as a mixture were identified by analysis of their 1 H NMR spectra including doublets at  7.35 -7.54 (H-7', J = 18 Hz) and  6.03-6.26 (H-8', J=18 Hz) as well as the aromatic H-2', H-5' and H-6' at  6.56 -6.98 (m) H-2 and H-6 at  1.87-2.22 while those attributed to H-3, H-4 and H-5 were detected at  3.88-4.42(m). Comparison of 13 C NMR and MS with the literature [17] , identified 3,4-(5), 3,5-(6) and 4,5-O-dicaffeoylquinic acid (7) . The occurrence of 5-7 is described for the first time in B. uncinella, but has been previously described in B. dracunculifolia, B. retusa, B. genistelloides, B. thesioide, B. trimera, and B. usterii [18] [19] .
Compounds 1-7 were tested in vitro against the trypomastigote forms of T. cruzi, by the colorimetric MTT method after 24 h incubation. Trypomastigote forms of T. cruzi were sensitive to caffeic acid (1), pectolinaringenin (4) and to the mixture of chlorogenic acids (5-7) with IC 50 values 51.61, 55.62 and 61.04 µg/mL, respectively (Tab. 1). Hispidulin (3) displayed moderate activity against trypomastigotes, with IC 50 values of 80.61 µg/mL while ferulic acid (2) was ineffective at IC 50 >150 g/mL. Similarly, compound 2 previously isolated from B. dracunculifolia showed weak activity (IC 50 =220 µg/mL) against trypomastigote forms of the Y strain of Trypanosoma cruzi [12] . 4,5-O-dicaffeoylquinic acid (7) is known to have activity against T. cruzi, suggesting that it may be, at least in part, responsible for the activity the chlorogenic acid mixture [20] . Benznidazole (IC 50 =114.7µg/mL) is the only available drug prescribed for T. cruzi, and has been successfully used in the treatment of acute infections [1] . Our results indicated that caffeic acid (1), pectolinaringenin (4) and the chlorogenic acid mixture (5-7) had IC 50 values, at least 2-fold more effective compared to benznidazole.
In order to evaluate the mammalian toxicity, NCTC cells were incubated with the isolated compounds and the viability of cells was determined by the MTT method. Considering the 95% confidence intervals, hispidulin (3) and benznidazole showed the similar CC 50 values (129 and 122 µg/mL, respectively). The most active compound, pectolinaringenin (4), showed an IC 50 of 75 µg/mL resulting in selectivity index of 1.4, while chlorogenic acids showed no toxicity at concentration of 150 µg/mL (Table 1) . IC 50 -50% Inhibitory Concentration (95% confidence interval); Cytotoxicity studies were performed in mammalian cells and the viability was detected by the MTT method. Data were obtained using sigmoidal dose-response analysis.
Considering the intense inflammatory effects in Chagas disease [21] , the therapeutical studies with nonsteroidal anti-inflammatory drugs (NSAIDs) as co-adjuvant for treatment [22] and the antiinflammatory effects of pectolinaringenin [11] , these results contribute with a novel prototype for future drug design and/or combinatorial studies. Finally, is noteworthy that all isolated compounds eliminated 100% of trypomastigotes at the highest tested concentrations (100 µg/mL), except for ferulic acid (2). Furthermore, the trypanocidal effect of compounds 1-7 was confirmed based in the lack of mitochondrial oxidative metabolism of parasites, which could be detected by MTT assay [23] . Considering the 95% confidence interval and the respective p values, mixture 5-7 demonstrated a similar effect to the standard drug benznidazole against trypomastigotes. Instruments: 1 H and 13 C NMR spectra were recorded on Bruker AC-200 and Bruker DPX-300 operating at 200/50 and 300/75 MHz, respectively. Spectra were measured in CDCl 3 or CD 3 OD with tetramethylsilane (TMS) as internal standard. The chemical shifts () are given in ppm and coupling constants (J) are given in Hz. Semi-preparative HPLC was performed using a Dionex Ultimate 3000 chromatograph equipped with a Luna C18 column (250 x 10 mm, 5 m i.d., Phenomenex, USA) and a UVD-DAD detector. Sephadex LH-20 (Amersham Biosciences) was used for column chromatographic separation, while silica gel 60 PF254 (Merck) was used for analytical TLC (0.25 mm). LRESIMS spectra were recorded in a VG Platform II-Micromass spectrometer (positive and negative modes).
Extraction and isolation:
The EtOH extract (13.0 g) obtained from dried aerial parts of B. uncinella (402 g) was suspended in MeOH:H 2 O 1:2. After partition using hexanes, EtOAc and n-BuOH, the three phases were evaluated for anti-trypanosomal activity. As the EtOAc and n-BuOH phases displayed activity, part of EtOAc phase (3.0 g) was chromatographed over Sephadex LH-20 (30x2cm), using MeOH as eluent to give 45 10mL fractions which were pooled in five groups (A1-A5), after TLC analysis. Groups A2 (904 mg) and A4 (33 mg) showed anti-trypanossomal activity and were individually purified by reversed phase (C 18 ) semi-prep HPLC (MeOH:H 2 O 7:3, flow rate at 2.8 mL/min) to give caffeic (1, 7 mg) and ferulic acids (2, 5 mg) from group A2 as well as hispidulin (3, 7 mg) and pectolinaringenin (4, 11 mg) from group A4. The active n-BuOH phase (2.0 g) was subjected to Sephadex LH-20 column chromatography (30x2cm), using MeOH as eluent to afford 29 13mL fractions. After TLC analysis, these fractions were pooled into ten groups (B1 -B10) in which the activity was detected in B8 (50 mg) which was a mixture of 3,4-(5), 3,5-(6) and 4,5-O-dicaffeoylquinic acids (7) .
Parasites and mammalian cells:
Trypomastigotes of T. cruzi (Y strain) were maintained in LLC-MK2 (ATCC CCL 7) cells using RPMI-1640 medium supplemented with 2% calf serum at 37ºC in a 5% CO 2 incubator.
Anti-trypanosomal activity:
Trypomastigotes obtained from LLC-MK2 cultures were counted in a Neubauer hemocytometer and seeded at 1 x 10 6 cells/well in 96-well microplates. The substances were incubated at the highest concentration of 150 µg/mL for 24 h at 37 o C in a 5% CO 2 humidified incubator using benznidazole as standard drug. The trypomastigotes viability was determined by the MTT method [23] .
Antitrypanosomal constituents from Baccharis uncinella Natural Product Communications Vol. 9 (2) 2014 173 Cytotoxicity assay: NCTC clone 929 cells were seeded at 6x10 4 cells/well in 96-well microplates at 37°C in a 5% CO 2 incubator. The mammalian cells were further incubated with test compounds to the highest concentration of 200 µg/mL for 48 h at 37°C, using benznidazole as a standard drug. The viability of the cells was determined by MTT assay at 550nm. The selectivity index (SI) was determined by the following equation: CC 50 against NCTC cells / IC 50 against parasites.
Statistical analysis:
The data obtained represent the mean and standard deviation of duplicate samples from two independent assays. The IC 50 values were calculated using sigmoid doseresponse curves in Graph Pad Prism 5.0 software, and the 95% confidence intervals are included in parentheses.
